Advancements in DKA Management Guidelines

This chapter explores the updated 2025 guidelines for diabetic ketoacidosis (DKA), highlighting new fluid administration protocols and the role of the SQUID trial in treatment advancements. It discusses the critical relationship between potassium levels and insulin therapy initiation while challenging past beliefs about gastrointestinal paralysis in DKA patients. Additionally, the chapter examines the cautious use of sodium bicarbonate in critical care, emphasizing its selective application rather than routine use.